McAdam LLC’s Invesco S&P 500 Equal Weight Health Care ETF RSPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$374K Sell
11,259
-829
-7% -$25.8K 0.01% 330
2026
Q1
$365K Sell
12,088
-166
-1% -$5.32K 0.02% 302
2025
Q4
$390K Sell
12,254
-1,043
-8% -$32.4K 0.02% 280
2025
Q3
$391K Sell
13,297
-44,223
-77% -$1.28M 0.02% 250
2025
Q2
$1.68M Sell
57,520
-2,435
-4% -$69.3K 0.09% 108
2025
Q1
$1.78M Sell
59,955
-3,448
-5% -$105K 0.11% 95
2024
Q4
$1.86M Sell
63,403
-6,752
-10% -$208K 0.1% 105
2024
Q3
$2.26M Sell
70,155
-28,601
-29% -$895K 0.13% 88
2024
Q2
$2.97M Sell
98,756
-2,346
-2% -$71.2K 0.18% 68
2024
Q1
$3.21M Sell
101,102
-1,808
-2% -$55.5K 0.21% 63
2023
Q4
$3.06M Sell
102,910
-3,683
-3% -$101K 0.22% 58
2023
Q3
$2.92M Sell
106,593
-4,337
-4% -$126K 0.24% 57
2023
Q2
$3.31M Sell
110,930
-3,510
-3% -$103K 0.27% 53
2023
Q1
$3.34M Sell
114,440
-36,800
-24% -$1.07M 0.3% 55
2022
Q4
$4.85M Buy
151,240
+25,740
+21% +$717K 0.48% 37
2022
Q3
$3.15M Sell
125,500
-5,130
-4% -$141K 0.34% 49
2022
Q2
$3.5M Sell
130,630
-11,870
-8% -$336K 0.37% 52
2022
Q1
$4.37M Sell
142,500
-8,740
-6% -$262K 0.41% 40
2021
Q4
$4.85M Sell
151,240
-2,150
-1% -$65.4K 0.48% 37
2021
Q3
$4.57M Sell
153,390
-4,100
-3% -$126K 0.51% 35
2021
Q2
$4.84M Sell
157,490
-4,250
-3% -$120K 0.55% 31
2021
Q1
$4.34M Sell
161,740
-12,420
-7% -$330K 0.61% 27
2020
Q4
$4.75M Sell
174,160
-13,470
-7% -$335K 0.73% 23
2020
Q3
$4.42M Buy
187,630
+2,360
+1% +$55.6K 0.84% 23
2020
Q2
$4.12M Buy
185,270
+9,150
+5% +$196K 0.87% 23
2020
Q1
$3.33M Buy
176,120
+8,920
+5% +$189K 0.9% 24
2019
Q4
$3.7M Buy
167,200
+11,410
+7% +$238K 0.89% 24
2019
Q3
$3.05M Buy
155,790
+8,510
+6% +$169K 0.83% 24
2019
Q2
$2.98M Buy
147,280
+10,370
+8% +$202K 0.89% 24
2019
Q1
$2.7M Buy
136,910
+6,560
+5% +$127K 0.9% 24
2018
Q4
$2.31M Buy
130,350
+18,120
+16% +$344K 0.91% 24
2018
Q3
$2.31M Buy
112,230
+12,670
+13% +$248K 0.85% 23
2018
Q2
$1.82M Buy
99,560
+15,730
+19% +$285K 0.74% 23
2018
Q1
$1.51M Buy
83,830
+31,080
+59% +$578K 0.69% 23
2017
Q4
$924K Hold
52,750
0.65% 24
2017
Q3
$924K Buy
52,750
+8,800
+20% +$153K 0.65% 24
2017
Q2
$765K Buy
43,950
+7,200
+20% +$119K 0.62% 24
2017
Q1
$588K Buy
36,750
+7,720
+27% +$120K 0.55% 25
2016
Q4
$424K Buy
+29,030
New +$429K 0.42% 28

Other funds holding RSPH

McAdam LLC's RSPH Position: Q2 2026 in Review

McAdam LLC reduced its Invesco S&P 500 Equal Weight Health Care ETF (RSPH) stake by 6.9% in Q2 2026, selling an estimated $25.8K and leaving 11,259 shares worth $374K. The position accounts for 0.01% of the portfolio, ranked #330.

McAdam LLC first reported a position in RSPH in Q4 2016 and has held it in 39 quarters since. The position peaked at $4.85M in Q4 2022. 187 funds tracked by Wall St. Rank hold RSPH as of Q2 2026.

  • McAdam LLC held 11,259 shares of Invesco S&P 500 Equal Weight Health Care ETF worth $374K as of Q2 2026.
  • McAdam LLC sold 829 Invesco S&P 500 Equal Weight Health Care ETF shares in Q2 2026, an estimated $25.8K.
  • Invesco S&P 500 Equal Weight Health Care ETF made up 0.01% of McAdam LLC's portfolio in Q2 2026, its #330 holding.
  • McAdam LLC first reported a position in Invesco S&P 500 Equal Weight Health Care ETF in Q4 2016 and has held it in 39 quarters since.
  • McAdam LLC's Invesco S&P 500 Equal Weight Health Care ETF position peaked at $4.85M in Q4 2022.
  • 187 funds tracked by Wall St. Rank held Invesco S&P 500 Equal Weight Health Care ETF as of Q2 2026.

Based on McAdam LLC's 13F filing for Q2 2026, filed 4 Aug 2026.